TL;DR
Mitosis and the cell cycle were found to affect the progression of EMC to EAOC and the expression of FOS, a novel biomarker, was identified to enhance the malignant potential of eutopic endometrial stromal cells in patients with EM-associated ovarian cancer.
AI-generated by Semantic Scholar
Authors
Junyu Chen, Kang He, Xin Li, Mengqi Wang, Zhaoyun Yang, Zeyu Wang, Kai Wang, Weiqiang Jiang, Lijing Zhao, Manhua Cui